GLP-1 weight loss medications (Wegovy, Zepbound, Foundayo) prescribed by a real clinician, paired with personalized nutrition and ongoing monitoring
These insights have driven the development of synthetic GLP-1R/GCGR co-agonists aimed at achieving long-term metabolic benefits
Although further research is ongoing, research studies show that vitamin B12 deficiency itself can cause pronounced exhaustion and fatigue
Beyond its metabolic role, NAD+ also participates in DNA repair and cell signaling, making it essential for maintaining cellular health and viability
Summary Breath changes are a common patient-reported issue with GLP-1 drugs, with the American Dental Association noting that about 30% of Ozempic users report bad breath, and one analysis showed a 15% higher chance of halitosis for semaglutide patients
Its showing what we would expect with peptides, Birks Ang says